Acorda Therapeutics (ACOR)

32.13 -0.27  -0.83%  May 22, 2:07PM
Add to Watchlists Create an Alert

Acorda Therapeutics Cash from Investing TTM:

-71.28M for Dec. 31, 2012
View Full Chart

Acorda Therapeutics Cash from Investing TTM Chart

    Acorda Therapeutics Historical Cash from Investing TTM Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 -71.28M
    Sept. 30, 2012 -74.35M
    June 30, 2012 -76.31M
    March 31, 2012 -108.21M
    Dec. 31, 2011 -45.02M
    Sept. 30, 2011 -70.02M
    June 30, 2011 -47.52M
    March 31, 2011 2.563M
    Dec. 31, 2010 5.351M
    Sept. 30, 2010 89.03M
    June 30, 2010 24.22M
    March 31, 2010 16.83M
    Dec. 31, 2009 -16.41M
       
    Sept. 30, 2009 -89.54M
    June 30, 2009 -67.49M
    March 31, 2009 -102.04M
    Dec. 31, 2008 -141.29M
    Sept. 30, 2008 -100.80M
    June 30, 2008 -53.26M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro

    About Cash From Investing (TTM)

    Definition: Cash from Investing

    Learn More

    Get data for

    ACOR Cash from Investing TTM Benchmarks

    Companies
    Discovery Laboratories -0.618M
    Biogen Idec -795.02M
    Osiris Therapeutics 13.23M

    ACOR Cash from Investing TTM Rankings

    Overall 60th percentile
    3144 of 8005
    Sector 31st percentile
    473 of 686 in Healthcare
    Industry 23rd percentile
    190 of 248 in Biotechnology

    ACOR Cash from Investing TTM Range, Past 5 Years

    Minimum -141.29M Dec 2008
    Maximum 89.03M Sep 2010
    Average -48.71M